DaVita HealthCare Surges Past S&P 500 Gains with Positive EPS and Revenue Projections

DaVita HealthCare (DVA) outpaced the stock market with a +1.94% gain, beating the S&P 500's 1.15% and Dow's 1.38% gains. The company is expected to post an EPS of $2.41, a 20.5% growth YoY, and revenue of $3.3 billion, a 2.36% rise YoY. DVA's full-year Zacks Consensus Estimates predict earnings of $14.16 per share and revenue of $14.11 billion, a 31.35% and 3.41% YoY growth, respectively. The stock has a Zacks Rank of #2 (Buy) and a Forward P/E ratio of 10.55, lower than the industry average of 17.33.